373 References 239. Preziosa P, Kiljan S, Steenwijk MD, Meani A, van de Berg WDJ, Schenk GJ, et al. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex. Brain. 2019;142:1921-37. 240. Uchihara T. Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol. 2007;113(5):483-99. 241. Ulfig N, Nickel J, Bohl J. Monoclonal antibodies SMI 311 and SMI 312 as tools to investigate the maturation of nerve cells and axonal patterns in human fetal brain. Cell Tissue Res. 1998;291(3):433-43. 242. Holmgren A, Bouhy D, Timmerman V. Neurofilament phosphorylation and their proline-directed kinases in health and disease. Journal of the Peripheral Nervous System. 2012;17(4):365-76. 243. Luchicchi A, Hart B, Frigerio I, van Dam AM, Perna L, Offerhaus HL, et al. AxonMyelin Unit Blistering as Early Event in MS Normal Appearing White Matter. Annals of Neurology. 2021;89(4):711-25. 244. Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133(1):1324. 245. Carriel V, Campos A, Alaminos M, Raimondo S, Geuna S. Staining Methods for Normal and Regenerative Myelin in the Nervous System. Methods Mol Biol. 2017;1560:207-18. 246. Klioueva NM, Rademaker MC, Huitinga I. Design of a European code of conduct for brain banking. Handbook of Clinical Neurology. 2018;150:51-81. 247. Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N, et al. BrainNet Europe’s Code of Conduct for brain banking. J Neural Transm. 2015;122(7):937-40. 248. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389-404. 249. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211. 250. Shan L, Balesar R, Swaab DF, Lammers GJ, Fronczek R. Reduced Numbers of Corticotropin-Releasing Hormone Neurons in Narcolepsy Type 1. Ann Neurol. 2022;91(2):282-8. 251. Shan L, Linssen S, Harteman Z, den Dekker F, Shuker L, Balesar R, et al. Activated Wake Systems in Narcolepsy Type 1. Ann Neurol. 2023;94(4):762-71. 252. Frigerio I, Laansma MA, Lin CP, Hermans EJM, Bouwman MMA, Bol JGJM, et al. Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia. Transl Neurodegener. 2023;12(1). 253. Fuller PM, Sherman D, Pedersen NP, Saper CB, Lu J. Reassessment of the structural basis of the ascending arousal system. J Comp Neurol. 2011;519(5):933-56. 254. Grady FS, Boes AD, Geerling JC. A Century Searching for the Neurons Necessary for Wakefulness. Front Neurosci. 2022;16:930514. 255. Lai YY, Kodama T, Siegel JM. Changes in monoamine release in the ventral horn and hypoglossal nucleus linked to pontine inhibition of muscle tone: an in vivo microdialysis study. J Neurosci. 2001;21(18):7384-91. 256. Lai YY, Kodama T, Schenkel E, Siegel JM. Behavioral response and transmitter release during atonia elicited by medial medullary stimulation. J Neurophysiol. 2010;104(4):2024-33. 12
RkJQdWJsaXNoZXIy MjY0ODMw